Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Bennett, Charles
One or more keywords matched the following items that are connected to Bennett, Charles
Item TypeName
Concept Costs and Cost Analysis
Concept Drug Costs
Concept Cost Savings
Concept Health Care Costs
Concept Cost-Benefit Analysis
Concept Hospital Costs
Concept Cost of Illness
Concept Cost Control
Academic Article Toxicity and costs of toxicity associated with new cancer drugs: international implications.
Academic Article Estimating the cost effectiveness of atovaquone versus intravenous pentamidine in the treatment of mild-to-moderate Pneumocystis carinii pneumonia.
Academic Article Granulocyte-macrophage colony-stimulating factor (GM-CSF) as adjunct therapy in relapsed Hodgkin disease.
Academic Article Medical care costs of intravenous drug users with AIDS in Brooklyn.
Academic Article Free-riding and the prisoner's dilemma: problems in funding economic analyses of phase III cancer clinical trials.
Academic Article Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: implications for economic analyses of phase III clinical trials.
Academic Article Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991.
Academic Article Estimating the cost effectiveness of total androgen blockade with flutamide in M1 prostate cancer.
Academic Article The effect of reimbursement policies on the management of Medicare patients with refractory ovarian cancer.
Academic Article Economic analysis in phase III clinical cancer trials.
Academic Article Economic analysis during phase III clinical trials: who, what, when, where, and why?
Academic Article Performance measurement in prostate cancer care: beyond report cards.
Academic Article Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers?
Academic Article A review of the costs, cost-effectiveness and third-party charges of bone marrow transplantation.
Academic Article Economic analyses of new technologies: the case of stem-cell transplantation.
Academic Article Treatment considerations for persons with metastatic prostate cancer: survival versus out-of-pocket costs.
Academic Article Health care economics and bone marrow transplantation.
Academic Article Economic analyses of phase III cooperative cancer group clinical trials: are they feasible?
Academic Article Treating malignant pleural effusions cost consciously.
Academic Article Cancer insurance policies in Japan and the United States.
Academic Article Economic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: what do we know?
Academic Article Cost-effectiveness analysis comparing liposomal anthracyclines in the treatment of AIDS-related Kaposi's sarcoma.
Academic Article Health economics in the treatment of colorectal cancer.
Academic Article Cost-effectiveness model of a phase II clinical trial of a new pharmaceutical for essential thrombocythemia: is it helpful to policy makers?
Academic Article Cost analyses of adjunct colony stimulating factors for older patients with acute myeloid leukaemia : can they improve clinical decision making?
Academic Article Cost analyses of granulocyte colony stimulating factor: a focus on older patients with cancer.
Academic Article Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries.
Academic Article Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms.
Academic Article The financial burden of cancer: estimates from a study of insured women with breast cancer.
Academic Article Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000.
Academic Article Pharmacoeconomics of liposomal anthracycline therapy.
Academic Article Granulocyte colony--stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisited.
Academic Article Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans.
Academic Article Local perspective of the impact of the HIPAA privacy rule on research.
Academic Article When the risk of febrile neutropenia is 20%, prophylactic colony-stimulating factor use is clinically effective, but is it cost-effective?
Academic Article Responding to a small-scale bioterrorist anthrax attack: cost-effectiveness analysis comparing preattack vaccination with postattack antibiotic treatment and vaccination.
Academic Article Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients.
Academic Article Cost considerations in the management of cancer in the older patient.
Academic Article Cancer-associated neutropenic fever: clinical outcome and economic costs of emergency department care.
Academic Article Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening.
Academic Article Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center.
Academic Article Upping recruitment in clinical trials: are the costs worth it?
Academic Article Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening.
Academic Article The excessive cost of early stage bladder cancer care: are providers really to blame?
Academic Article Cost-effectiveness comparison of response strategies to a large-scale anthrax attack on the chicago metropolitan area: impact of timing and surge capacity.
Academic Article Primary prophylaxis with hematopoietic colony stimulating factor: insights from a Canadian cost-effectiveness analysis.
Academic Article Improving colon cancer screening in community clinics.
Academic Article Strategies to improve repeat fecal occult blood testing cancer screening.
Academic Article Erythropoietin, a novel repurposed drug: an innovative treatment for wound healing in patients with diabetes mellitus.
Academic Article Economics of Malignant Gliomas: A Critical Review.
Academic Article Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia. Eastern Cooperative Oncology Group (E1490).
Academic Article Cost-effectiveness models of clinical trials of new pharmaceuticals for AIDS-related Pneumocystis carinii pneumonia: are they helpful to policy makers?
Academic Article Sustaining mammography screening among the medically underserved: a follow-up evaluation.
Academic Article Associations Between Industry Sponsorship and Results of Cost-effectiveness Analyses of Drugs Used in Breast Cancer Treatment.
Academic Article Relationship of Industry Sponsorship to Results of Cost-Effectiveness Analyses of Drugs Used in Breast Cancer Treatment--Reply.
Academic Article Federal 340B Program Payment Scheme for Drugs Designated As Orphan Products: Congressional Clarification Needed to Close the Government-Industry Revolving Door.
Academic Article Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA.
Academic Article Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia.
Academic Article Biosimilars-Curb Your Enthusiasm.
Academic Article Why Biologics and Biosimilars Remain So Expensive: Despite Two Wins for Biosimilars, the Supreme Court's Recent Rulings do not Solve Fundamental Barriers to Competition.
Academic Article Biosimilar Filgrastim Use in the United States vs the European Union and Japan-Why Does It Lag Behind and What Can Be Done?
Academic Article Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada.
Academic Article Pharmacoeconomics of amifostine in ovarian cancer.
Academic Article Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation.
Academic Article Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center 1989 to 1995.
Academic Article Evaluation of conflict of interest in economic analyses of new drugs used in oncology.
Academic Article Cost analysis of second-line therapies for platinum-refractory ovarian cancer: reimbursement dilemmas for Medicare patients.
Academic Article The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: results from the 1997 American Society of Clinical Oncology survey. Health Services Research Committee of the American Society of Clinical Oncology.
Academic Article Does reimbursement affect physician decision making?
Academic Article Cost analysis of filgrastim for the prevention of neutropenia in pediatric T-cell leukemia and advanced lymphoblastic lymphoma: a case for prospective economic analysis in cooperative group trials.
Academic Article Cost-effectiveness analysis of pegylated-liposomal doxorubicin and liposomal daunorubicin treatments in patients with Kaposi's sarcoma.
Academic Article The potential for treatment of idiopathic thrombocytopenic purpura with anti-D to prevent splenectomy: a predictive cost analysis.
Academic Article Cost analyses of adjunct colony stimulating factors for acute leukemia: can they improve clinical decision making.
Academic Article Comparing cost-effectiveness analyses for the clinical oncology setting: the example of the Gynecologic Oncology Group 111 trial.
Academic Article Purchasing oncology services. Kerr L. White Institute/American Cancer Society Task Force on Purchasing Oncology Services.
Academic Article Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project.
Academic Article Comparative study of the clinical efficacy of two dosing regimens of flutamide.
Academic Article Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer.
Academic Article Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.
Academic Article Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: preliminary results from a randomized phase II clinical trial from Germany.
Academic Article Pricing, profits and pharmacoeconomics--for whose benefit?
Academic Article Costs of terminal care for people with AIDS.
Academic Article Clinical trials: are they a good buy?
Academic Article Cost-effectiveness considerations in the treatment of essential thrombocythemia.
Academic Article Evaluating the total costs of cancer. The Northwestern University Costs of Cancer Program.
Academic Article Humira: the first $20 billion drug.
Search Criteria
  • Costs and Cost Analysis